Of the many pathologic changes associated with myocardial ischemia, contractile dysfunction is one of the leading causes of postischemic morbidity and mortality. Contractile dysfunction can generally be classified into two categories, reversible, commonly called stunning, and irreversible, as in infarction. Understanding reversible injury provides the best means of developing interventions to prevent contractile dysfunction. The broad long term goals of this project are to demonstrate how protein oxidation can result in reversible contractile dysfunction. In this application we will examine the concept that contractile functional recovery is dependent on removal of oxidized proteins by the 20S-proteasome setting the stage for de novo synthesis of new proteins; and that apoptosis of stunning is partially related to a disequilibrium between pro- and antiapoptotic proteins as a result of selective inhibition of the 26S-proteasome.
Specific Aim 1 examines the hypothesis that recovery of function of stunned myocardium is partially dependent on 20S- proteasome removal of oxidized actin. Using actin as a model we will determine if oxidation of this protein results in loss of sarcomeric actin and disruption of the myocyte cytoskeleton; and if recovery of function is partially dependent on removal by the 20S-proteasome and de novo synthesis to reestablish proper sarcomeric and cytoskeletal integrity.
Specific Aim 2 examines the hypothesis that the 26S- proteasome is selectively inhibited by oxidative phenomena and exposure to lipofuscin-like materials during ischemia.
Specific Aim 3 examines the hypothesis that inhibition of the 26S-proteosome during stunning leads to disequilibrium between pro- and anti-apoptotic factors. We will examine the role of the 26S-proteasome in dysregulation of the cell cycle protein p53, the cyclin-dependent kinase inhibitor, p27kip1, and the cell death mediator, Bax. These experiments will be performed in a variety of models including an isolated heart preparation, an in vivo model of postischemic recovery, and in cultured neonatal cardiomyocytes. These studies have the potential to explain why some cardiomyocytes are lost and others survive and recover function and ultimately could aid identification of sites for therapeutic intervention. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL068936-02
Application #
6760023
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Liang, Isabella Y
Project Start
2003-07-01
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
2
Fiscal Year
2004
Total Cost
$380,720
Indirect Cost
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030
McCarthy, Mary K; Malitz, Danielle H; Molloy, Caitlyn T et al. (2016) Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection. Virology 498:57-68
Wang, Xuejun; Robbins, Jeffrey (2014) Proteasomal and lysosomal protein degradation and heart disease. J Mol Cell Cardiol 71:16-24
Day, Sharlene M; Divald, Andras; Wang, Ping et al. (2013) Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure. Circ Heart Fail 6:544-9
Wang, Xuejun; Pattison, J Scott; Su, Huabo (2013) Posttranslational modification and quality control. Circ Res 112:367-81
Ranek, Mark J; Terpstra, Erin J M; Li, Jie et al. (2013) Protein kinase g positively regulates proteasome-mediated degradation of misfolded proteins. Circulation 128:365-76
Wang, Xuejun (2013) Repeated intermittent administration of a ubiquitous proteasome inhibitor leads to restrictive cardiomyopathy. Eur J Heart Fail 15:597-8
Wang, Xuejun; Terpstra, Erin J M (2013) Ubiquitin receptors and protein quality control. J Mol Cell Cardiol 55:73-84
Lei, Daoxiong; Li, Faqian; Su, Huabo et al. (2013) Hepatic deficiency of COP9 signalosome subunit 8 induces ubiquitin-proteasome system impairment and Bim-mediated apoptosis in murine livers. PLoS One 8:e67793
Calise, Justine; Powell, Saul R (2013) The ubiquitin proteasome system and myocardial ischemia. Am J Physiol Heart Circ Physiol 304:H337-49
Powell, Saul R; Herrmann, Joerg; Lerman, Amir et al. (2012) The ubiquitin-proteasome system and cardiovascular disease. Prog Mol Biol Transl Sci 109:295-346

Showing the most recent 10 out of 40 publications